Clinical Observation of V-P Shunt and Application of "Three-step Disinfection" to Reduce Post-operative Infection Rate
A Prospective Clinical Observation of Ventriculo-Peritoneal Shunt in Patients With Normal or Low Hydrocephalus and A Multi-Center Randomized Controlled Study on Application of "Three-step Disinfection" in Reducing the Incidence of Post-operative Infection
2 other identifiers
interventional
600
1 country
1
Brief Summary
A randomized, single blind, parallel controlled, multicenter clinical study was performed in which patients who had undergone a cerebrospinal fluid to peritoneal shunt that met the criteria were divided into two groups (test and control) in a 1:1 ratio, with the test group applied disinfection by the "three-step sterilization method" and completed the procedure, and the control group underwent the same surgical procedure according to the routine aseptic disinfection procedure, relevant literatures were reviewed and the previous ones in our hospital were summarized, it is intended to conduct a one-year clinical observation of the two groups, to compare the perioperative and long-term infection incidence of the two groups and evaluate them comprehensively, to evaluate whether the "three-step sterilization method" disinfected patients have reduced perioperative and long term infection risk after surgery compared with previous surgery with routine disinfection procedure, and to evaluate their effectiveness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 3, 2021
CompletedFirst Posted
Study publicly available on registry
March 5, 2021
CompletedStudy Start
First participant enrolled
June 30, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedJune 30, 2021
June 1, 2021
1.8 years
March 3, 2021
June 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Rate of postoperation Intracranial infection
post-operation intracranial infection(diagnosed by lumbar puncture)
10 days post-operation to 12 month post-operation
Rate of postoperation Intra-abdominal infection
Post-operation abdominal-cavity infection(diagnosed by WBC counting and clinical feature)
10 days post-operation to 12 month post-operation
Secondary Outcomes (2)
Rate of Ventriculoperitoneal shunt malfunction
10 days post-operation to 12 month post-operation
Rate of postoperation Surgical wound infection
10 days post-operation to 12 month post-operation
Other Outcomes (2)
Barthel Index of activities of daily living
prior operation and 6\12 month time point
Glasgow coma scale(GCS)
prior operation and 10 days post-operation to 12 month post-operation
Study Arms (2)
Controlled group
NO INTERVENTIONthe routine preoperative disinfection method
Three-step disinfection
EXPERIMENTALnew developed method of preoperative disinfection
Interventions
Three step disinfection method can be divide in three part. The first step of disinfection: scalp dandruff removal + disinfection The second step of disinfection: whole head Use 2% iodine tincture to smear the whole head skin, the assistant helps to lift the head to expose the surgical field, from both eyebrows to the occipital hairline, from both sides to the neck, after the iodine tincture dry out, use 75% alcohol to deionize. Then placing more than 4 layers of operation towel under the head. The third step of disinfection: neck chest abdomen disinfection.
Eligibility Criteria
You may qualify if:
- Age ≥ 18, regardless of gender.
- Patients with hydrocephalus of high, normal and low pressure caused by various reasons need V-P shunt and meet the operation indications.
- Before the start of the trial, a written informed consent signed by the subject himself or his legal representative must be obtained.
You may not qualify if:
- Patients who had participated in clinical trials of other drugs or medical devices within 6 months.
- Patients with abnormal coagulation mechanisms or who had received treatment with thrombolytic agents, anticoagulants, or inhibitors of platelet coagulation within 2 weeks, and patients with hemophilia.
- Patients with severe diseases of other systems, such as severe diseases of the hematological, respiratory, digestive, and urinary systems, were combined.
- Patients with co-existing infectious diseases.
- Pregnant, lactating female patient.
- Physicians judged other situations in which they could not participate in the trial.
- The subjects themselves or their legal surrogates refused to participate in the clinical trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Baiyun Liulead
Study Sites (1)
Beijing TianTan Hospital affliated to Capital Medical University
Beijing, Beijing Municipality, China
Related Publications (7)
Wu Y, Green NL, Wrensch MR, Zhao S, Gupta N. Ventriculoperitoneal shunt complications in California: 1990 to 2000. Neurosurgery. 2007 Sep;61(3):557-62; discussion 562-3. doi: 10.1227/01.NEU.0000290903.07943.AF.
PMID: 17881969BACKGROUNDMcGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sexton DJ. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis. 2003 Apr 1;36(7):858-62. doi: 10.1086/368191. Epub 2003 Mar 18.
PMID: 12652386BACKGROUNDChoux M, Genitori L, Lang D, Lena G. Shunt implantation: reducing the incidence of shunt infection. J Neurosurg. 1992 Dec;77(6):875-80. doi: 10.3171/jns.1992.77.6.0875.
PMID: 1432129BACKGROUNDRozzelle CJ, Leonardo J, Li V. Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial. J Neurosurg Pediatr. 2008 Aug;2(2):111-7. doi: 10.3171/PED/2008/2/8/111.
PMID: 18671615BACKGROUNDWorking Group on Neurosurgical Outcomes Monitoring; Woo PY, Wong HT, Pu JK, Wong WK, Wong LY, Lee MW, Yam KY, Lui WM, Poon WS. Primary ventriculoperitoneal shunting outcomes: a multicentre clinical audit for shunt infection and its risk factors. Hong Kong Med J. 2016 Oct;22(5):410-9. doi: 10.12809/hkmj154735. Epub 2016 Aug 26.
PMID: 27562986BACKGROUNDErps A, Roth J, Constantini S, Lerner-Geva L, Grisaru-Soen G. Risk factors and epidemiology of pediatric ventriculoperitoneal shunt infection. Pediatr Int. 2018 Dec;60(12):1056-1061. doi: 10.1111/ped.13709. Epub 2018 Dec 10.
PMID: 30290047BACKGROUNDYang YN, Zhang J, Gu Z, Song YL. The risk of intracranial infection in adults with hydrocephalus after ventriculoperitoneal shunt surgery: A retrospective study. Int Wound J. 2020 Jun;17(3):722-728. doi: 10.1111/iwj.13331. Epub 2020 Feb 19.
PMID: 32073232BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Baiyun Liu, Ph.D
Beijing Tiantan Hospital affiliate to Capital Medical University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor, Chief Physician
Study Record Dates
First Submitted
March 3, 2021
First Posted
March 5, 2021
Study Start
June 30, 2021
Primary Completion
April 1, 2023
Study Completion
April 1, 2024
Last Updated
June 30, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share